SEC Form 4 · accession 0001127602-17-023516
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Jul 10, 2017
Accepted (ET)
Jul 12, 2017 · 7:11 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2017 | S | 100 | $98.995 | D | 351,562 | D | |
| Common Stock | Jul 10, 2017 | S | 838 | $99.00 | D | 350,724 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.005 | D | 350,624 | D | |
| Common Stock | Jul 10, 2017 | S | 826 | $99.01 | D | 349,798 | D | |
| Common Stock | Jul 10, 2017 | S | 502 | $99.02 | D | 349,296 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.025 | D | 349,196 | D | |
| Common Stock | Jul 10, 2017 | S | 200 | $99.03 | D | 348,996 | D | |
| Common Stock | Jul 10, 2017 | S | 101 | $99.04 | D | 348,895 | D | |
| Common Stock | Jul 10, 2017 | S | 5 | $99.045 | D | 348,890 | D | |
| Common Stock | Jul 10, 2017 | S | 287 | $99.05 | D | 348,603 | D | |
| Common Stock | Jul 10, 2017 | S | 6 | $99.055 | D | 348,597 | D | |
| Common Stock | Jul 10, 2017 | S | 1,401 | $99.06 | D | 347,196 | D | |
| Common Stock | Jul 10, 2017 | S | 526 | $99.07 | D | 346,670 | D | |
| Common Stock | Jul 10, 2017 | S | 300 | $99.08 | D | 346,370 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.085 | D | 346,270 | D | |
| Common Stock | Jul 10, 2017 | S | 300 | $99.09 | D | 345,970 | D | |
| Common Stock | Jul 10, 2017 | S | 98 | $99.095 | D | 345,872 | D | |
| Common Stock | Jul 10, 2017 | S | 908 | $99.10 | D | 344,964 | D | |
| Common Stock | Jul 10, 2017 | S | 301 | $99.105 | D | 344,663 | D | |
| Common Stock | Jul 10, 2017 | S | 400 | $99.11 | D | 344,263 | D | |
| Common Stock | Jul 10, 2017 | S | 167 | $99.115 | D | 344,096 | D | |
| Common Stock | Jul 10, 2017 | S | 600 | $99.13 | D | 343,496 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.135 | D | 343,396 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.14 | D | 343,296 | D | |
| Common Stock | Jul 10, 2017 | S | 300 | $99.16 | D | 342,996 | D | |
| Common Stock | Jul 10, 2017 | S | 598 | $99.18 | D | 342,398 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.